Liselotte S. Ebbesen

Author

Also Known As

L S Ebbesen, L. S. EBBESEN, L. S. Ebbesen, L.S. EBBESEN, Laura Ebbesen, Liselotte S Ebbesen, Liselotte S. Ebbesen, Liselotte Sabroe Ebbesen

Publications

645

Citations

H-Index

Concepts

All Affiliations

Aarhus University Hospital Novo Nordisk (Denmark)University of Pennsylvania GTx (United States)Academia Nacional de Medicina

About

Liselotte S. Ebbesen is an author at Aarhus University Hospital specializing in medicine, hematology, and atherosclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	468
2	Health Sciences	2	2	347
3	Natural Sciences	1	1	14
4	Biochemistry	1	1	14
5	Cell Biology	1	1	14

Liselotte S. Ebbesen

Publications

636

Citations

H-Index

Page 1

	Year	Citations
Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors Barbara A. Konkle, Liselotte S. Ebbesen, Elisabeth Erhardtsen, Journal of Thrombosis and Haemostasis ThrombosisSecondary ProphylaxisHematologyClinical TrialsRecombinant Factor Viia	2007	325
Secondary prophylaxis with recombinant activated factor VII improves health‐related quality of life of haemophilia patients with inhibitors W. Keith Hoots, Liselotte S. Ebbesen, Barbara A. Konkle, Haemophilia	2008	95
Leukocyte-depletion of blood components does not significantly reduce the risk of infectious complications Ingrid Louise Titlestad, Liselotte S. Ebbesen, Alan Patrick Ainsworth, International Journal of Colorectal Disease GranulocyteBlood ComponentsTransfusion MedicineInfectious ComplicationsImmunology	2001	93
Evaluation of thromboelastography for monitoring recombinant activated factor VII ex vivo in haemophilia A and B patients with inhibitors: a multicentre trial Guy Young, Liselotte S. Ebbesen, Dorthe Viuff, Blood Coagulation & Fibrinolysis	2008	58
Hyperhomocysteinemia, thrombosis and vascular biology. Liselotte S. Ebbesen PubMed Vascular DiseaseGenetic EpidemiologyPathologyHyperlipidemiaOxidative Stress	2004	22
Randomized, Prospective Clinical Trial of rFVIIa for Secondary Prophylaxis in Hemophilia Patients with Inhibitors. Barbara A. Konkle, Liselotte S. Ebbesen, Ute Friedrich, Blood	2006	15
Folate deficiency induced hyperhomocysteinemia changes the expression of thrombosis-related genes Liselotte S. Ebbesen, S.H. Olesen, Mogens Kruhøffer, Blood Coagulation & Fibrinolysis GeneticsImmunologyPathologyEpigeneticsAplastic Anemia	2006	14
Hyperhomocysteinemia Due to Folate Deficiency Is Thrombogenic in Rats Liselotte S. Ebbesen, Kirsten Christiansen, Jørgen Ingerslev Journal of Nutrition MedicineInherited Metabolic DiseaseHematologyHyperhomocysteinemia DueMetabolism	2003	14

Page 1